Contact
searchSearch
HMP Global
Login

Videos

James Greenblatt, MD
Videos
Incorporating Integrative Approaches Into Psychiatric Care
08/05/2026
James Greenblatt, MD
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses...
08/05/2026
Psych Congress Network
Craig Chepke and Kevin Williams
Major Depressive Disorder Insights
Aligning Patient Goals With Novel Mechanisms in MDD Anhedonia Treatment
07/28/2026
Craig Chepke, MD, DFAPA; Kevin Williams, MS, MPAS, PA-C
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
Craig Chepke, MD, DFAPA, and...
07/28/2026
Psych Congress Network
Brittany Albright, MD, MPH
Distinguishing Schizophrenia From Substance-Induced Psychosis Part 2
Learn how Brittany Albright, MD, MPH, develops a treatment strategy for a young patient struggling with adherence and medication tolerability.
Arwen Podesta, MD, DFAPA, DFASAM
Videos
Improving Alcohol Use Disorder Care With Pharmacologic Treatment
07/24/2026
Arwen Podesta, MD
In this conversation with PCN, Arwen Podesta, MD, DFAPA, DFASAM, discusses how medication-assisted therapy (MAT) may improve patient outcomes in alcohol use disorder (AUD).
In this conversation with PCN, Arwen Podesta, MD, DFAPA, DFASAM, discusses how medication-assisted therapy (MAT) may improve patient outcomes in alcohol use disorder (AUD).
In this conversation with PCN,...
07/24/2026
Psych Congress Network
Jill Harkavy-Friedman, PhD
Videos
Taking a Comprehensive Approach to Suicide Risk Assessment in Clinical Practice
07/20/2026
Jill Harkavy-Friedman, PhD
Jill Harkavy-Friedman, PhD, walks clinicians through what a comprehensive assessment of suicide risk looks like in clinical practice.
Jill Harkavy-Friedman, PhD, walks clinicians through what a comprehensive assessment of suicide risk looks like in clinical practice.
Jill Harkavy-Friedman, PhD,...
07/20/2026
Psych Congress Network
Rakesh Jain, MD, MPH
Videos
The Sleep Disorder Missteps Clinicians Can Learn From
07/16/2026
Rakesh Jain, MD, MPH, RD
Rakesh Jain, MD, MPH, Co-Chair, Psych Congress discusses why sleep complaints in psychiatric practice warrant direct evaluation rather than dismissal as secondary symptoms.
Rakesh Jain, MD, MPH, Co-Chair, Psych Congress discusses why sleep complaints in psychiatric practice warrant direct evaluation rather than dismissal as secondary symptoms.
Rakesh Jain, MD, MPH, Co-Chair,...
07/16/2026
Psych Congress Network
Kristian Dambrino, DNP, PMHNP-BC
Videos
Knowing When to Initiate Treatment for TD
07/07/2026
Kristian Dambrino, DNP, PMHNP, MSN
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair...
07/07/2026
Psych Congress Network
Kristian Dambrino, DNP, PMHNP-BC
Videos
Knowing When to Initiate Treatment for TD
07/07/2026
Kristian Dambrino, DNP, PMHNP, MSN
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair...
07/07/2026
Psych Congress Network
Craig Chepke and Kevin Williams
Major Depressive Disorder Insights
Anhedonia in MDD: What to Ask When Visit Time Is Short
07/07/2026
Craig Chepke, MD, DFAPA; Kevin Williams, MS, MPAS, PA-C
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how busy outpatient clinicians can effectively screen for anhedonia in major depressive disorder.
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how busy outpatient clinicians can effectively screen for anhedonia in major depressive disorder.
Craig Chepke, MD, DFAPA, and...
07/07/2026
Psych Congress Network
Brittany Albright, MD, MPH
Distinguishing Schizophrenia From Substance-Induced Psychosis Part 1
Brittany Albright, MD, MPH, explores the diagnosis of an 18-year-old college freshman after his second psychiatric hospitalization during his first semester.

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Desiree Matthews, PHMNP-BC; Amber Hoberg, MSN, APRN, PMHNP-BC
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use